TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News:
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced operating and financial results for the second quarter and six months ended June 30, 2008. For the second quarter of 2008, EpiCept’s net loss attributable to common stockholders was $7.8 million, or $0.15 per share, compared with a net loss attributable to common stockholders of $7.0 million, or $0.22 per share, for the second quarter of 2007. For the six months ended June 30, 2008, EpiCept’s net loss attributable to common stockholders was $13.8 million, or $0.28 per share, compared to $14.7 million, or $0.45 per share, for the six months ended June 30, 2007. As of June 30, 2008, EpiCept had approximately 59.3 million shares outstanding.
